Tag: diagnostic imaging market

Diagnostic Imaging Market is anticipated to reach US$ 49.29 Billion by 2028

Extensive industry analysis and market share data are available in the recently released report “Molecular Diagnostics Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2030″ by Renub Research. The study looks at the competitors, geographical areas, and growth potential of the clinical molecular diagnostics market.

Molecular Diagnostics Market is anticipated to expand at a compound annual growth rate (CAGR) of 7.40% from 2023 to 2030

At the nexus of biotechnology and healthcare lies the dynamic and quickly evolving molecular diagnostics market, encompassing a spectrum of technologies and strategies for analyzing biological markers at the molecular level to diagnose and display illnesses. Fueled by advancements in genomics, a heightened understanding of diseases’ molecular bases, and a growing emphasis on personalized medication, this market is characterized by non-stop innovation and strategic collaborations between international pharmaceutical companies and local healthcare establishments. With an unwavering awareness of addressing unmet medical needs, the molecular diagnostics market is poised for sustained growth, serving as a linchpin in shaping the future panorama of healthcare. 

Moreover, the molecular diagnostics market prospers on increasing expertise of disease molecular bases, coupled with technological breakthroughs that enhance diagnostic accuracy and inform therapeutic decisions. A growing emphasis on personalized remedies propels the demand for molecular diagnostics, enabling tailored cures based on individual genetic profiles. Ongoing innovation, driven by collaborations between worldwide pharmaceutical businesses and local healthcare establishments, addresses unmet medical desires and integrates cutting-edge technologies. This collaborative approach positions the market at the leading edge of imparting solutions for complex healthcare challenges. With advancing technology and deepening know-how of disease molecular bases, the molecular diagnostics market is set for sustained growth, emerging as a transformative force shaping the future of healthcare. Hence, the Global Molecular Diagnostics Market will therefore grow to a size of US$ 28.17 billion by 2030.

Likewise, in the molecular diagnostics market, PCR technology is pivotal for DNA amplification and detecting disease-associated genetic sequences. The versatile and precise PCR section holds an extensive percentage across numerous diagnostic packages. Simultaneously, diagnostics laboratories are vital for molecular testing services, gaining significance amid the growing demand for precision medication. Expected to maintain constant growth, this sector is propelled by enhanced diagnostic capabilities and the rising incidence of complex illnesses. Notably, with sturdy healthcare infrastructure and massive research investments, China emerges as a key growth contributor, exhibiting the quickest growth rate due to proactive government initiatives fostering advanced diagnostic generation adoption.

Due to its indispensable role in diagnostic testing, the reagents segment is poised to sustain its leading position in the molecular diagnostics market

 

As a fundamental element, reagents are crucial for various molecular diagnostic strategies, including PCR and DNA sequencing. The ongoing advancements in molecular diagnostics, coupled with a surge in demand for accurate and speedy testing strategies, ensure the continued prominence of the reagents section. Its pivotal feature in enabling precise molecular evaluation positions it to preserve a central role in the foreseeable future of molecular diagnostics.

Product Segment – The Molecular Diagnostics Market has been covered from three viewpoints.

  1. Reagents& kits
  2. Instruments
  3. Software& Services

The oncology sector anticipates a substantial growth rate in the molecular diagnostics market

Advancements in genomic and molecular studies have led to the development of targeted therapies and personalized remedy alternatives for cancer patients. This has amplified the need for unique and early cancer detection, driving the adoption of molecular diagnostics. Also, the increasing occurrence of cancer instances internationally further propels the growth of molecular diagnostics in oncology, making it a high-capability segment with a promising growth rate.

Application – The Molecular Diagnostics Market has been covered from five viewpoints

  1. Oncology
  2. Infectious Disease
  3. Genetic Testing
  4. Blood Screening
  5. Others

Due to its unparalleled role in DNA amplification, the Polymerase Chain Reaction (PCR) segment commands the highest share in the molecular diagnostics market.

Widely employed for its accuracy and sensitivity, PCR is pivotal in detecting and quantifying genetic material, facilitating disease diagnosis and monitoring. The versatility of PCR applications, ranging from infectious diseases to genetic disorders, makes it a cornerstone technology. Its robust performance, efficiency, and broad diagnostic utility contribute to the PCR segment’s dominance in holding the highest market share.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=global-molecular-diagnostics-market-opportunities-and-future-forecast-414-p.php

Technology – The Global Molecular Diagnostics Market has been covered from six viewpoints

  1. Polymerase Chain Reaction
  2. Hybridization
  3. Isothermal Nucleic Amplification Technology (INAAT)
  4. Chips & Microarrays
  5. DNA Sequencing
  6. Others (Mass Spectrometry, TMA)

The diagnostics laboratories are poised to sustain their growth in the molecular diagnostics market because of their central role in precise and comprehensive testing services

As the demand for molecular diagnostics grows, laboratories play a crucial role in conducting complex tests and interpreting results accurately. The increasing prevalence of infectious diseases, genetic disorders, and cancer necessitates advanced diagnostic capabilities, further propelling the significance of Diagnostics Laboratories. This sector’s expertise in molecular testing positions it to maintain its pivotal role throughout the forecast period.

End-User – Global Molecular Diagnostics Market has been covered from three viewpoints

  1. Hospitals & Clinics
  2. Diagnostics Laboratories
  3. Others

During the forecast period, China is anticipated to exhibit the fastest growth in the molecular diagnostics market

The robust healthcare infrastructure in the United States, rising investments in research and development, and a large population contribute to increased demand for advanced diagnostics. Also, the growing awareness of personalized medicine and the prevalence of chronic diseases drive the adoption of molecular diagnostics in China. According to the World Health Organization (WHO), chronic diseases account for 88% of all deaths in China. The leading chronic diseases in China are cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes. Favorable government initiatives and an expanding middle class further accelerate market growth, positioning China as a key player in the industry.

Countries

  1. United States
  2. Canada
  3. Germany
  4. United Kingdom
  5. France
  6. Italy
  7. Spain
  8. Switzerland
  9. Japan
  10. China
  11. India
  12. Australia
  13. South Korea
  14. Indonesia
  15. Brazil
  16. Argentina
  17. Mexico
  18. South Africa
  19. Saudi Arabia
  20. United Arab Emirates
  21. Rest of World

Competitive Landscape

Prominent companies in the molecular diagnostics market include Abbott Laboratories, Myriad Genetics, Roche Diagnostics, BioMerieux SA, Danaher Corporation, Qiagen NV, Bio-rad Laboratories Inc., and Hologic (Gen-Probe).

Company Insights

  • Overview
  • Recent Development and Initiatives
  • Sales Analysis

Molecular Diagnostics Market Companies

  • Abbott Laboratories
  • Myriad Genetics
  • Roche Diagnostics
  • BioMerieux SA
  • Danaher Corporation
  • Qiagen NV
  • Bio-rad Laboratories Inc.
  • Hologic (Gen-Probe)

Related Reports

Teleradiology Market size is expected to reach US$ 17.38 Billion by 2030

Clinical Chemistry Analyzer Market size is expected to attain US$ 19.02 Billion by 2030

Lung Cancer Screening Market size is projected to reach US$ 4.36 Billion by 2028

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://linkedin.com/company/renub-research

Website: www.renub.com

Diagnostic Imaging Market, Size | Growth Forecast | 2028

Industry Trends, Share, Growth, Company Analysis,” Diagnostic Imaging Market valued at US$ 35.11 Billion in 2022. Medical imaging uses technology to produce internal body images for clinical analysis or medical intervention in a non-invasive manner. As medical technology advances, the market for Diagnostic Imaging continues to evolve, fuelling the growing demand for patient-centric healthcare. As a result, the industry must focus on critical R&D investments to adapt the constant changes while fulfilling customer needs.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/diagnostic-imaging-market-p.php

Global Diagnostic Imaging Market is anticipated to with a CAGR of 5.82% from 2022 to 2028

With the advent of novel technologies and rapid digitalization, the global medical devices industry is jumping leaps and bounds in growth and development. From new and emerging business models to accelerated innovation in many areas of diagnostics, care delivery, connected health, data security, supply chain, process automation, etc., the healthcare landscape is hovering around the idea of disruptive possibilities owing to several trends.

For example, there is a significant shift in R&D spending patterns and talent trends, collaborations with start emphasis on ups, tech giants, service providers, and overall digital and connected health. Medical imaging is one such segment of the MedTech industry that has significantly benefited from the trends mentioned above. 

X-Ray is primarily used in the Diagnostic Imaging Market

The primary need for early diagnosis is the cause of the upsurge in X-ray demand. However, along with the need for early diagnosis, factors such as technological advancements in various applications, massive spending in product R&D, growing investments in healthcare infrastructure, and the need for visible improvements in population health technologies are driving the growth in medical imaging.

 Request a free sample copy of the report:  https://www.renub.com/request-sample-page.php?gturl=diagnostic-imaging-market-p.php

Orthopaedic application segment captured most of the Market Share

The ever-growing incidence of chronic diseases worldwide, an aging population, rising awareness, and priority for health are increasing the demand for early diagnosis. An additional factor relevant in a scenario is the predominant use of X systems to diagnose COVID ray and CT-19 cases worldwide. As a result, the burden of chronic diseases is rising globally, and medical imaging procedures are crucial in accurately diagnosing chronic diseases.

Furthermore, the aging population and socioeconomic changes are leading to a continuous rise in these prevalent and costly long-term health conditions. Cancer, cardiovascular disease, obesity, and diabetes account for the majority of chronic illness mortality. According to GLOBOCAN, around 19.3 million new cancer cases were recorded worldwide in 2020, with this figure anticipated to rise to 30.2 million by 2040. The emerging markets would be the most affected, as population growth is expected to be greatest in developing nations.

Hospitals lead the Global Diagnostic Imaging Market

Currently, hospitals comprise the most significant share; however, the adoption of imaging systems by diagnostic centers is expected to capture the highest CAGR during the upcoming years. The growing number of private imaging centers, fueled by rising demand for diagnostic imaging treatments, is likely to boost hospital segment growth. Companies strive to attain market equilibrium by investing in technology to meet rising demand. From a macroeconomic standpoint, suitable investments bear fruit for all stakeholders in such ecosystems.

Furthermore, for instance, in November 2021, Canon Medical Systems USA, Inc., a leading manufacturer of diagnostic devices, announced the launch of Vantage Fortran, an innovative remote tablet and in-room camera solutions for monitoring and positioning patients to enhance workflow.

North American region will lead in the Global Diagnostic Imaging Market

North America is owing to the higher demand for medical imaging modalities such as Ultrasound, MRI, X-rays, and CT scans in hospital settings for accurate diagnosis during treatment. In addition, the availability of advanced medical imaging devices in hospitals and sound infrastructure leads to the segmental growth of hospitals. Similarly, the presence of skilled healthcare professionals in hospitals to accurately treat and diagnose patients surge the demand for medical imaging in hospitals. Additionally, rising cases of chronic diseases and an increasing number of hospital admissions will further accelerate the medical imaging market progression.

Key Players

The worldwide imaging industry is at a crossroads and will profoundly change during the next decade with novel technologies and new players entering and redefining the competitive landscape. The incumbent equipment manufacturers face increasing competition from new entrants such as Samsung Electronics, Neusoft Medical Systems, or Mindray Medical in emerging and developed markets. In addition, the leading contrast media companies will see increasing generic competition as the remaining contrast agent patents expire within the following years. 

Market Summary:

  • Product- the Report Covers Diagnostic Imaging Market by type in 6 viewpoints (X-Ray, CT, Ultrasound, MRI, Nuclear Imaging, and Others).
  • Application – Diagnostic Imaging Market by treatment breakup in 5 viewpoints (Orthopedics, Cardiovascular, Neurology, Pelvic & Abdomen, Oncology).
  • End-Users – The Diagnostic Imaging Market breakup into three viewpoints (Hospitals, Diagnostic Centres, and Others).
  • Region- Renub Research Report covers by Diagnostic Imaging Market region in 5 viewpoints (North America, Europe, Asia Pacific, South America, and Middle East & Africa).
  • Key Players: All the major players have been covered from 3 Viewpoints (Overview, Recent Development, and Financial Insights) FUJIFILM VisualSonics Inc., Canon Medical Systems Corporation, Bruker, PerkinElmer Inc., Hitachi, Hologic, Radnet and Koninklijke Philips.

Browse Related Report:

United States Biopsy Market, Size, Forecast 2023-2028

Cosmetic Surgery Market, Size, Global Forecast 2023-2027

Clinical Chemistry Market, Size, Global Forecast 2023-2027

Autoimmune Disease Diagnostic Market, Size, Global Forecast 2021-2027

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com LinkedIn: https://in.linkedin.com/company/renub-research